方剂复合应用3例

Prescription Composite Applications Three Cases Report

下载PDF

导出

摘要方剂复合是中医治疗疾病主要手段,也是临床用药基本形式。有学者借用物理学术语,称之为"耦合"效应。新组合方剂,运用得当,起到增效、协同、叠加作用。复合应用疗效优于单一方剂加减。用药并非多多益善,须辨证精当,深研本草,熟悉药性,抓主要矛盾,疗效第一,经得起临床验证。 The “compound” refers to the combination of two or more prescriptions, efficacy, indications vary, complex and difficult to treat disease. Clinical effect on composite applications to explore for prescriptions, noting the efficacy of traditional Chinese medicine prescription composite applications better than a single prescription subtraction. Joint Clinical efficacy of clinical use of Chinese herbs significantly, quick, safe and reliable, worthy of wide application and promotion.

作者刘少庭祝河霞查方勇徐军李向波周城林

机构地区湖北省郧西县中医院内科

出处《实用中医内科杂志》 2014年第11期122-123,共2页 Journal of Practical Traditional Chinese Internal Medicine

关键词方剂复合应用耦合中医药治疗前列腺增生腹泻出汗 Prescription Composite applications Chinese medicine treatment Epidemic rash Gains Senseto permit series Huanglianjiedu soup Jiao Shude Wei Changchun

分类号 R289 [医药卫生—方剂学] R288 [医药卫生—中药学]

引文网络
相关文献

参考文献5

1Sharp GC, Irvin WG, et al.Mixed connective tissue disease:an apparently distinct rheumatic disease sydrome associated with a specific antibody to an extractable nuclear antigen ( ENA ) [ J ] .Am JMed, 1972, 52 (2): 148-159.
2Hoffman RW, Bezruczko N, Perkins K.An external validation study of a classification of mixed connective tissue disease and systemic lupus erythematosus patients [ J ] .J Appl Meas, 2012, 13 ( 2 ) : 205-216.
3陈灏珠.实用内科学[M].13版.北京:人民卫生出版社,2002:1632.
4Enldennk F, Cats A.Fatal primary pulmonary hypertension in mixed connective tissue disease [ J ] .Z Rhumtol, 1998, 40 ( 2 ) : 25-29.
5雷云霞,张晓.结缔组织病相关的肺动脉高压[J].岭南心血管病杂志,2012,18(5):460-462. 被引量：2

二级参考文献15

1荆志成.2010年中国肺高血压诊治指南[J].中国医学前沿杂志（电子版）,2011,3(2):62-81. 被引量：117
2GALIE N,HOEPER M M,HUMBERT M. Guidelines for the diagnosis and treatment of pulmonary hypertension:the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS),endorsed by the International Society of Heart and Lung Transplantation (ISHLT)[J].European Heart Journal,2009,(20):2493-2537.
3MCLAUGHLIN V V,ARCHER S L,BADESCH D B. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of the Chest Physicians; American Thoracic Society,Inc.; and the Pulmonary Hypertension Association[J].Journal of the American College of Cardiology,2009,(17):1573-1619.
4British Cardiac Society Guidelines and Medical Practice Committee. Recommendations on the management of pulmonary hypertension in clinical practice[J].Heart,2001,(Suppl 1):I1-I13.
5SIMONNEAU G,GALI(E) N,RUBIN L J. ClinicaI classification of pulmonary hypertension[J].Journal of the American College of Cardiology,2004,(12 Suppl S):5S-12S.doi:10.1016/j.jacc.2004.02.037.
6MORSE J,BARST R,HORN E. Pulmonary hypertension in scleroderma spectrum of disease:lack of bone morphogenetic protein receptor 2 mutations[J].Journal of Rheumatology,2002,(11):2379-2381.
7TAMBY M C,CHANSEAUD Y,HUMBERT M. Antiendothelial ceil antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension[J].Thorax,2005,(09):765-772.
8STEEN V D,MEDSGER T. Changes in causes of death in systemic sclerosis,1972-2002[J].Annals of the Rheumatic Diseases,2007,(07):940-944.
9MCGOON M,GUTTERMAN D,STEEN V D. Screening,early detection,and diagnosis of pulmonary arterial hypertension:ACCP evidence-based clinical practice guidelines[J].Chest,2004,(Suppl):14S-34S.
10HOEPER M M,PLETZ M W,GOLPON H. Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension[J].European Respiratory Journal,2007,(05):944-950.

共引文献1

1耿健,汲泓.归脾汤+舒血宁+昆仙胶囊联合西医治疗混合性结缔组织病合并慢性心功能不全1例报告[J].实用中医内科杂志,2014,28(11):117-118.

1蒋天佑,蒋玮,蒋琰.应用活血化瘀法治疗疑难杂病的体会[J].山西中医,2004,20(1):4-5.
2容小翔.补药并非多多益善[J].养生月刊,2002,0(9):395-395.
3董绍军.豆腐营养好多吃也不宜[J].解放军健康,2010(1):35-35.
4王雨晴.头针复合疗法治疗中风探讨[J].内蒙古中医药,2009,28(11X):20-20.
5任晖.颈丛阻滞复合针刺麻醉在甲状腺手术中的应用体会[J].中国麻醉与镇痛,2005,7(1):46-47. 被引量：2
6秋季进补忌无病乱补忌多多益善[J].心血管病防治知识,2011(11):76-76.
7徐培平,符林春,张奉学,胡英杰.方剂配伍中的“耦合”效应[J].中医杂志,2009,50(1):8-10. 被引量：5
8高和平,牛春风,王保华.针麻和颈丛阻滞复合应用行甲状腺手术临床观察[J].长春中医学院学报,1999,15(4):29-29. 被引量：6
9钱红梅,许平武,匡萍.针麻与颈丛麻醉复合应用于甲状腺手术临床观察[J].河南中医,2009,29(12):1224-1224. 被引量：5
10雷泽玉,秦伟霞,张玉凤.复合与单用电针、手法整复治疗颞颌关节功能紊乱综合征[J].中国临床康复,2003,7(14):2120-2121.

实用中医内科杂志

2014年第11期

浏览历史

内容加载中请稍等...

方剂复合应用3例

参考文献5

二级参考文献15

共引文献1

相关作者

相关机构

相关主题

浏览历史